Parp As A Therapeutic Target
Download Parp As A Therapeutic Target full books in PDF, epub, and Kindle. Read online free Parp As A Therapeutic Target ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
PARP as a Therapeutic Target
Author | : Jei Zhang |
Publisher | : CRC Press |
Total Pages | : 363 |
Release | : 2002-03-06 |
Genre | : Medical |
ISBN | : 1420042408 |
Download PARP as a Therapeutic Target Book in PDF, Epub and Kindle
Recent research in cell death mechanisms has rekindled interest in PARP's (Poly (ADP-Ribose) Polymerase) intriguing role in necrosis and apoptosis. While the details of how PARP1 functions are still being elucidated, it has tremendous potential as a promising drug target. PARP inhibitors' dual actions of preventing cell death and abating inflammati
PARP as a Therapeutic Target Related Books
Language: en
Pages: 363
Pages: 363
Type: BOOK - Published: 2002-03-06 - Publisher: CRC Press
Recent research in cell death mechanisms has rekindled interest in PARP's (Poly (ADP-Ribose) Polymerase) intriguing role in necrosis and apoptosis. While the de
Language: en
Pages: 590
Pages: 590
Type: BOOK - Published: 2015-06-13 - Publisher: Humana Press
PARP Inhibitors for Cancer Therapy provides a comprehensive overview of the role of PARP in cancer therapy. The volume covers the history of the discovery of PA
Language: en
Pages: 99
Pages: 99
Type: BOOK - Published: 2016-08-05 - Publisher: Frontiers Media SA
Poly-ADP ribose polymerase (PARP) proteins are critical mediators of DNA repair. Many traditional anti-cancer chemotherapy agents overwhelm a cell’s ability t
Language: en
Pages: 260
Pages: 260
Type: BOOK - Published: 2008-01-11 - Publisher: Springer Science & Business Media
This is the most comprehensive, up-to-date reference on this post-translational modification of proteins, which is intimately linked with DNA repair, maintenanc
Language: en
Pages: 358
Pages: 358
Type: BOOK - Published: 2002-12-31 - Publisher: Springer Science & Business Media
One of the most exciting areas of cancer research now is the development of agents which can target signal transduction pathways that are activated inappropriat